CEPI and GSK announced collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
On Feb. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, and GSK announced a new collaboration aimed…
On Feb. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, and GSK announced a new collaboration aimed…
On Feb. 3, 2020, the CDC released the 2020 recommended immunization schedules for children and adolescents, as well…
On Jan. 31, 2020, Mammoth Biosciences announced the company had received a contract from the National Institutes of…
On Jan. 31, 2020, Vaxart announced it had initiated a program to develop a coronavirus vaccine candidate based…
On Jan 31, 2020, Taconic Biosciences announced that it had expanded its immuno-oncology portfolio with the launch of…
On Jan. 31, 2020, the U.S. Departments of Health and Human Services announced that as a result of…
On Jan. 30, 2020, The WHO announced that the outbreak of a deadly and fast-spreading strain of coronavirus…
On Jan. 30, 2020, the Centers for Disease Control and Prevention (CDC) confirmed that the 2019 Novel Coronavirus…
On Jan. 30, 2020, the University of Washington (UW) announced that a new center was being created with…
On Jan. 29, 2020, 23andMe announced an agreement with Almirall to in-license 23andMe’s bispecific monoclonal antibody designed to…
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
On Jan. 28, 2020, the Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, met President…
On Jan. 28, 2020, AbCellera confirmed that it had mobilized its pandemic response platform against the ongoing outbreak…
On Jan. 28, 2020, Alexion Pharma announced it had completed its acquisition of Achillion Pharmaceuticals for $930 million….
On Jan. 27, 2020, the Jackson Laboratory announced it was one of the founding partners of the Roux…
On Jan. 27, 2020, GSK announced that it had licensed its M72/AS01E[3] tuberculosis disease (TB) vaccine candidate to…
On Jan. 27, 2020, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had recruited its…
On Jan. 26, 2020, the Bill & Melinda Gates Foundation announced that it had immediately committed $10 million…
On Jan. 24, 2020, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…
On Jan. 23, 2020, the new cluster of viral pneumonia cases originating in Wuhan, China, marked the third…
On Jan. 23, 2020, two independent meningitis B studies were published in the New England Journal of Medicine…
On Jan. 23, 2020, Moderna announced a new collaboration to develop an mRNA vaccine against the novel coronavirus…
On Jan. 23, 2020, Vanderbilt University Medical Center researchers Megan Capozzi, PhD, John Penn, PhD, and colleagues showed…
On Jan. 23, 2020, the Vanderbilt Vaccine Research Program (VVRP) received a grant from the National Institutes of…
On Jan. 22, 2020, Vir Biotech announced it was working to rapidly determine whether its previously identified anti-coronavirus…
On Jan. 22, 2020, Johns Hopkins engineering professor Dr. Lauren Gardner created the COVID dashboard used around the…
On Jan. 20, 2020, deCODE genetics reported a genome-wide association meta-analysis of 69,189 cases and 702,199 controls from…
On Jan. 17, 2020, the World Health Organization (WHO) reported that declining private investment and lack of innovation…
On Jan. 17, 2020, the Non-profit drug developer TB Alliance granted Shenyang Hongqi Pharmaceuticals , a subsidiary of…
On Jan. 16, 2020, the Barbara Ann Karmanos Cancer Institute received the President’s Trophy for the second year…